Cypherpunk Technologies Inc. (CYPH) News
Track canonical SquawkNews coverage tagged to CYPH, Cypherpunk Technologies Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Cypherpunk Technologies Reports Q2 2026 Results
Cypherpunk Technologies reports second quarter 2026 financial results
EARNINGS | Aug 12, 2026, 11:05 AM UTC
L
CYPH: Leap Therapeutics Publishes DeFianCe Study
Leap Therapeutics announces publication of DeFianCe study results
EQUITY | Aug 12, 2026, 11:00 AM UTC
H
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ: LIMN ) stock increased by 40.9% to $0.16 during Thursday's pre-market session. The market value of their outstanding shares is at $5.8 million. Stablecoin Development (AMEX: SDEV ) stock
EARNINGS | Jul 02, 2026, 12:05 PM UTC
L
Cantor Fitzgerald Initiates Coverage On Cypherpunk Technologies with Overweight Rating, Announces Price Target of $0.9
Cantor Fitzgerald analyst Gareth Gacetta initiates coverage on Cypherpunk Technologies (NASDAQ: CYPH ) with a Overweight rating and announces Price Target of $0.9.
EQUITY | Jul 01, 2026, 02:31 PM UTC